Meridian Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $929K | Buy |
5,006
+69
| +1% | +$12.8K | 0.13% | 45 |
|
|
2025
Q1 | $1.03M | Sell |
4,937
-282
| -5% | -$59.1K | 0.17% | 42 |
|
|
2024
Q4 | $927K | Buy |
5,219
+192
| +4% | +$34.1K | 0.14% | 42 |
|
|
2024
Q3 | $993K | Buy |
5,027
+14
| +0.3% | +$2.77K | 0.15% | 42 |
|
|
2024
Q2 | $860K | Buy |
5,013
+157
| +3% | +$26.9K | 0.15% | 41 |
|
|
2024
Q1 | $884K | Buy |
4,856
+141
| +3% | +$25.7K | 0.16% | 40 |
|
|
2023
Q4 | $731K | Buy |
4,715
+82
| +2% | +$12.7K | 0.14% | 42 |
|
|
2023
Q3 | $691K | Buy |
4,633
+150
| +3% | +$22.4K | 0.14% | 41 |
|
|
2023
Q2 | $604K | Sell |
4,483
-43
| -1% | -$5.79K | 0.12% | 43 |
|
|
2023
Q1 | $721K | Buy |
4,526
+71
| +2% | +$11.3K | 0.16% | 36 |
|
|
2022
Q4 | $720K | Buy |
4,455
+185
| +4% | +$29.9K | 0.17% | 35 |
|
|
2022
Q3 | $573K | Buy |
4,270
+19
| +0.4% | +$2.55K | 0.14% | 40 |
|
|
2022
Q2 | $652K | Buy |
4,251
+688
| +19% | +$106K | 0.15% | 38 |
|
|
2022
Q1 | $578K | Buy |
3,563
+1,653
| +87% | +$268K | 0.12% | 46 |
|
|
2021
Q4 | $258K | Buy |
+1,910
| New | +$258K | 0.05% | 71 |
|
|
2021
Q2 | – | Sell |
-652
| Closed | -$70K | – | 84 |
|
|
2021
Q1 | $70K | Buy |
652
+50
| +8% | +$5.37K | 0.02% | 133 |
|
|
2020
Q4 | $65K | Buy |
602
+269
| +81% | +$29K | 0.03% | 122 |
|
|
2020
Q3 | $29K | Sell |
333
-134
| -29% | -$11.7K | 0.01% | 169 |
|
|
2020
Q2 | $46K | Buy |
+467
| New | +$46K | 0.02% | 133 |
|